Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolf, P. A.
Right arrow Articles by Kannel, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolf, P. A.
Right arrow Articles by Kannel, W. B.

Stroke, Vol 22, 983-988, Copyright © 1991 by American Heart Association


ARTICLES

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

PA Wolf, RD Abbott and WB Kannel
Department of Neurology, Evans Memorial Department of Clinical Research, Boston, Mass.

The impact of nonrheumatic atrial fibrillation, hypertension, coronary heart disease, and cardiac failure on stroke incidence was examined in 5,070 participants in the Framingham Study after 34 years of follow-up. Compared with subjects free of these conditions, the age-adjusted incidence of stroke was more than doubled in the presence of coronary heart disease (p less than 0.001) and more than trebled in the presence of hypertension (p less than 0.001). There was a more than fourfold excess of stroke in subjects with cardiac failure (p less than 0.001) and a near fivefold excess when atrial fibrillation was present (p less than 0.001). In persons with coronary heart disease or cardiac failure, atrial fibrillation doubled the stroke risk in men and trebled the risk in women. With increasing age the effects of hypertension, coronary heart disease, and cardiac failure on the risk of stroke became progressively weaker (p less than 0.05). Advancing age, however, did not reduce the significant impact of atrial fibrillation. For persons aged 80-89 years, atrial fibrillation was the sole cardiovascular condition to exert an independent effect on stroke incidence (p less than 0.001). The attributable risk of stroke for all cardiovascular contributors decreased with age except for atrial fibrillation, for which the attributable risk increased significantly (p less than 0.01), rising from 1.5% for those aged 50-59 years to 23.5% for those aged 80- 89 years. While these findings highlight the impact of each cardiovascular condition on the risk of stroke, the data suggest that the elderly are particularly vulnerable to stroke when atrial fibrillation is present.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
I van Wijk, P J Koudstaal, L J Kappelle, J van Gijn, J W Gorter, A Algra, and for the LiLAC Study Group
Long-term occurrence of death and cardiovascular events in patients with transient ischaemic attack or minor ischaemic stroke: comparison between arterial and cardiac source of the index event
J. Neurol. Neurosurg. Psychiatry, August 1, 2008; 79(8): 895 - 899.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Tanaka, Y. Ishikawa, M. Yokoyama, H. Origasa, M. Matsuzaki, Y. Saito, Y. Matsuzawa, J. Sasaki, S. Oikawa, H. Hishida, et al.
Reduction in the Recurrence of Stroke by Eicosapentaenoic Acid for Hypercholesterolemic Patients: Subanalysis of the JELIS Trial
Stroke, July 1, 2008; 39(7): 2052 - 2058.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. Schneider, R. Malisius, K. Krause, F. Lampe, E. Bahlmann, S. Boczor, M. Antz, S. Ernst, and K.-H. Kuck
Strain rate imaging for functional quantification of the left atrium: atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation
Eur. Heart J., June 1, 2008; 29(11): 1397 - 1409.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning
Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Chest, June 1, 2008; 133(6_suppl): 546S - 592S.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. D. Vagaonescu, A. C. Wilson, and J. B. Kostis
Atrial Fibrillation and Isolated Systolic Hypertension: The Systolic Hypertension in the Elderly Program and Systolic Hypertension in the Elderly Program-Extension Study
Hypertension, June 1, 2008; 51(6): 1552 - 1556.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Darbar, P. J. Kannankeril, B. S. Donahue, G. Kucera, T. Stubblefield, J. L. Haines, A. L. George Jr, and D. M. Roden
Cardiac Sodium Channel (SCN5A) Variants Associated with Atrial Fibrillation
Circulation, April 15, 2008; 117(15): 1927 - 1935.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. K. Voeller, M. S. Bailey, A. Zierer, S. C. Lall, S.-i. Sakamoto, K. Aubuchon, J. S. Lawton, N. Moazami, C. B. Huddleston, N. A. Munfakh, et al.
Isolating the entire posterior left atrium improves surgical outcomes after the Cox maze procedure.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 870 - 877.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Aull-Watschinger, H. Konstantin, D. Demetriou, M. Schillinger, A. Habicht, W. H. Horl, and B. Watschinger
Pre-transplant predictors of cerebrovascular events after kidney transplantation
Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1429 - 1435.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Stramba-Badiale
Atrial fibrillation subtypes, risk of stroke, and antithrombotic therapy
Eur. Heart J., April 1, 2008; 29(7): 840 - 842.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. L Garwood and T. L Corbett
Use of Anticoagulation in Elderly Patients with Atrial Fibrillation Who Are at Risk for Falls
Ann. Pharmacother., April 1, 2008; 42(4): 523 - 532.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Watanabe, N. Tanabe, T. Watanabe, D. Darbar, D. M. Roden, S. Sasaki, and Y. Aizawa
Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study
Circulation, March 11, 2008; 117(10): 1255 - 1260.
[Abstract] [Full Text] [PDF]


Home page
Occup Med (Lond)Home page
Z. Taimur and S. Hussaini
Atrial fibrillation in a commercial diver
Occup. Med., March 1, 2008; 58(2): 144 - 146.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. G. Douen, N. Pageau, and S. Medic
Serial Electrocardiographic Assessments Significantly Improve Detection of Atrial Fibrillation 2.6-Fold in Patients With Acute Stroke
Stroke, February 1, 2008; 39(2): 480 - 482.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. B. Goldstein and P. M. Rothwell
Advances in Prevention and Health Services Delivery 2007
Stroke, February 1, 2008; 39(2): 258 - 260.
[Full Text] [PDF]


Home page
CirculationHome page
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation, January 29, 2008; 117(4): e25 - e146.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A. G.G. Turpie
New oral anticoagulants in atrial fibrillation
Eur. Heart J., January 2, 2008; 29(2): 155 - 165.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. E. Cohn, I. D. Gregoric, B. Radovancevic, R. K. Wolf, and O.H. Frazier
Atrial Fibrillation After Cardiac Transplantation: Experience in 498 Consecutive Cases
Ann. Thorac. Surg., January 1, 2008; 85(1): 56 - 58.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
N.-H. Pan, H.-M. Tsao, N.-C. Chang, Y.-J. Chen, and S.-A. Chen
Aging Dilates Atrium and Pulmonary Veins: Implications for the Genesis of Atrial Fibrillation
Chest, January 1, 2008; 133(1): 190 - 196.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
R. K. Voeller, R. B. Schuessler, and R. J. Damiano Jr.
Surgical Treatment of Atrial Fibrillation
Card. Surg. Adult, January 1, 2008; 3(2008): 1375 - 1394.
[Full Text]


Home page
StrokeHome page
D. A. Lane and G. Y.H. Lip
Barriers to Anticoagulation in Patients With Atrial Fibrillation: Changing Physician-Related Factors
Stroke, January 1, 2008; 39(1): 7 - 9.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
M. B Nichol, T. K Knight, T. Dow, G. Wygant, G. Borok, O. Hauch, and R. O'Connor
Quality of Anticoagulation Monitoring in Nonvalvular Atrial Fibrillation Patients: Comparison of Anticoagulation Clinic versus Usual Care
Ann. Pharmacother., January 1, 2008; 42(1): 62 - 70.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
E. A. Nutescu
ASHP Therapeutic Position Statement on Antithrombotic Therapy in Chronic Atrial Fibrillation
Am. J. Health Syst. Pharm., November 1, 2007; 64(21): 2281 - 2291.
[Full Text] [PDF]


Home page
Age AgeingHome page
P. J. Barry, P. Gallagher, C. Ryan, and D. O'mahony
START (screening tool to alert doctors to the right treatment) an evidence-based screening tool to detect prescribing omissions in elderly patients
Age Ageing, November 1, 2007; 36(6): 632 - 638.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. Liao, Z. Khalid, C. Scallan, C. Morillo, and M. O'Donnell
Noninvasive Cardiac Monitoring for Detecting Paroxysmal Atrial Fibrillation or Flutter After Acute Ischemic Stroke: A Systematic Review
Stroke, November 1, 2007; 38(11): 2935 - 2940.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
M. Hughes, G.Y.H. Lip, and on behalf of the Guideline Development Group for t
Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review
QJM, October 1, 2007; 100(10): 599 - 607.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Baruch, B. F. Gage, J. Horrow, S. Juul-Moller, A. Labovitz, M. Persson, and M. Zabalgoitia
Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
Stroke, September 1, 2007; 38(9): 2459 - 2463.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
D. A Fitzmaurice, F D R. Hobbs, S. Jowett, J. Mant, E. T Murray, R. Holder, J P Raftery, S Bryan, M. Davies, G. Y H Lip, et al.
Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial
BMJ, August 25, 2007; 335(7616): 383 - 383.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Fatkin, R. Otway, and J. I. Vandenberg
Genes and Atrial Fibrillation: A New Look at an Old Problem
Circulation, August 14, 2007; 116(7): 782 - 792.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Y. Miyasaka, M. E. Barnes, R. C. Petersen, S. S. Cha, K. R. Bailey, B. J. Gersh, G. Casaclang-Verzosa, W. P. Abhayaratna, J. B. Seward, T. Iwasaka, et al.
Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort
Eur. Heart J., August 2, 2007; 28(16): 1962 - 1967.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Y.-J. Shen, J. F. Yao, S. S. Brar, M. B. Jorgensen, and W. Chen
Racial/Ethnic Differences in the Risk of Intracranial Hemorrhage Among Patients With Atrial Fibrillation
J. Am. Coll. Cardiol., July 24, 2007; 50(4): 309 - 315.
[Abstract] [Full Text] [PDF]


Home page
MMCTSHome page
R. J. Damiano Jr and M. Bailey
The Cox-Maze IV procedure for lone atrial fibrillation
MMCTS, July 23, 2007; 2007(0723): 2758.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Jahangir, V. Lee, P. A. Friedman, J. M. Trusty, D. O. Hodge, S. L. Kopecky, D. L. Packer, S. C. Hammill, W.-K. Shen, and B. J. Gersh
Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation: A 30-Year Follow-Up Study
Circulation, June 19, 2007; 115(24): 3050 - 3056.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
M. D. Gammage, J. V. Parle, R. L. Holder, L. M. Roberts, F. D. R. Hobbs, S. Wilson, M. C. Sheppard, and J. A. Franklyn
Association Between Serum Free Thyroxine Concentration and Atrial Fibrillation
Arch Intern Med, May 14, 2007; 167(9): 928 - 934.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
N. Anderson, R. Fuller, and N. Dudley
'Rules of thumb' or reflective practice? Understanding senior physicians' decision-making about anti-thrombotic usage in atrial fibrillation
QJM, May 1, 2007; 100(5): 263 - 269.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Rastas, A. Verkkoniemi, T. Polvikoski, K. Juva, L. Niinisto, K. Mattila, E. Lansimies, T. Pirttila, and R. Sulkava
Atrial Fibrillation, Stroke, and Cognition: A Longitudinal Population-Based Study of People Aged 85 and Older
Stroke, May 1, 2007; 38(5): 1454 - 1460.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. B. Rowan, D. N. Bailey, C. E. Bublitz, and R. J. Anderson
Trends in Anticoagulation for Atrial Fibrillation in the U.S.: An Analysis of the National Ambulatory Medical Care Survey Database
J. Am. Coll. Cardiol., April 10, 2007; 49(14): 1561 - 1565.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
A. N. Westover, S. McBride, and R. W. Haley
Stroke in Young Adults Who Abuse Amphetamines or Cocaine: A Population-Based Study of Hospitalized Patients
Arch Gen Psychiatry, April 1, 2007; 64(4): 495 - 502.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Miyasaka, M. E. Barnes, K. R. Bailey, S. S. Cha, B. J. Gersh, J. B. Seward, and T. S.M. Tsang
Mortality Trends in Patients Diagnosed With First Atrial Fibrillation: A 21-Year Community-Based Study
J. Am. Coll. Cardiol., March 6, 2007; 49(9): 986 - 992.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Ocorr, N. L. Reeves, R. J. Wessells, M. Fink, H.-S. V. Chen, T. Akasaka, S. Yasuda, J. M. Metzger, W. Giles, J. W. Posakony, et al.
KCNQ potassium channel mutations cause cardiac arrhythmias in Drosophila that mimic the effects of aging
PNAS, March 6, 2007; 104(10): 3943 - 3948.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. J. Tafreshi and J. Rowles
A Review of the Investigational Antiarrhythmic Agent Dronedarone
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 15 - 26.
[Abstract] [PDF]


Home page
Age AgeingHome page
A. Rash, T. Downes, R. Portner, W. W. Yeo, N. Morgan, and K. S. Channer
A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO)
Age Ageing, March 1, 2007; 36(2): 151 - 156.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. T. Akins, H. A. Feldman, R. G. Zoble, D. Newman, S. G. Spitzer, H.-C. Diener, and G. W. Albers
Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation: Pooled Analysis of SPORTIF III and V Clinical Trials
Stroke, March 1, 2007; 38(3): 874 - 880.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. Heeringa, D. A. M. van der Kuip, A. Hofman, J. A. Kors, F. J. A. van Rooij, G. Y. H. Lip, and J. C. M. Witteman
Subclinical Atherosclerosis and Risk of Atrial Fibrillation: The Rotterdam Study
Arch Intern Med, February 26, 2007; 167(4): 382 - 387.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. F. Mitchell, R. S. Vasan, M. J. Keyes, H. Parise, T. J. Wang, M. G. Larson, R. B. D'Agostino Sr, W. B. Kannel, D. Levy, and E. J. Benjamin
Pulse Pressure and Risk of New-Onset Atrial Fibrillation
JAMA, February 21, 2007; 297(7): 709 - 715.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Dagres, R. Nieuwlaat, P. E. Vardas, D. Andresen, S. Levy, S. Cobbe, D. Th. Kremastinos, G. Breithardt, D. V. Cokkinos, and H. J.G.M. Crijns
Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe: A Report From the Euro Heart Survey on Atrial Fibrillation
J. Am. Coll. Cardiol., February 6, 2007; 49(5): 572 - 577.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al.
Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Circulation, February 6, 2007; 115(5): e69 - e171.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. C. Lall, S. J. Melby, R. K. Voeller, A. Zierer, M. S. Bailey, T. J. Guthrie, M. R. Moon, N. Moazami, J. S. Lawton, and R. J. Damiano Jr
The effect of ablation technology on surgical outcomes after the Cox-maze procedure: A propensity analysis
J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 389 - 396.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
D. Grandmougin and O. Tiffet
Video-assisted thoracoscopic epicardial ablation of left pulmonary veins for lone permanent atrial fibrillation
Interactive CardioVascular and Thoracic Surgery, February 1, 2007; 6(1): 136 - 138.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al.
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
Eur. Heart J., January 1, 2007; 28(1): 88 - 136.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Kamohara, Z. B. Popovic, M. Daimon, M. Martin, Y. Ootaki, M. Akiyama, F. Zahr, F. Cingoz, C. Ootaki, M. W. Kopcak Jr, et al.
Impact of left atrial appendage exclusion on left atrial function
J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 174 - 181.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
L Kalra, G Y H Lip, and on behalf of the Guideline Development Group for t
Antithrombotic treatment in atrial fibrillation
Heart, January 1, 2007; 93(1): 39 - 44.
[Full Text] [PDF]


Home page
StrokeHome page
B. Wiberg, J. Sundstrom, J. Arnlov, A. Terent, B. Vessby, B. Zethelius, and L. Lind
Metabolic Risk Factors for Stroke and Transient Ischemic Attacks in Middle-Aged Men: A Community-Based Study With Long-Term Follow-Up
Stroke, December 1, 2006; 37(12): 2898 - 2903.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
I. C. Van Gelder and M. E.W. Hemels
The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm
Europace, November 1, 2006; 8(11): 943 - 949.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
S. J. Melby, S. L. Gaynor, J. G. Lubahn, A. M. Lee, P. Rahgozar, S. D. Caruthers, T. A. Williams, R. B. Schuessler, and R. J. Damiano Jr
Efficacy and safety of right and left atrial ablations on the beating heart with irrigated bipolar radiofrequency energy: A long-term animal study
J. Thorac. Cardiovasc. Surg., October 1, 2006; 132(4): 853 - 860.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
CirculationHome page
H. Oral, A. Chugh, M. Ozaydin, E. Good, J. Fortino, S. Sankaran, S. Reich, P. Igic, D. Elmouchi, D. Tschopp, et al.
Risk of Thromboembolic Events After Percutaneous Left Atrial Radiofrequency Ablation of Atrial Fibrillation
Circulation, August 22, 2006; 114(8): 759 - 765.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the Europ